News
-
-
-
COMMUNIQUÉ DE PRESSE
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
Applied DNA Sciences, Inc. undergoes workforce reduction to focus on LineaRx synthetic DNA manufacturing. Ceases operations at Applied DNA Clinical Labs. Strategic decisions for growth and operational efficiency -
-
-
-
COMMUNIQUÉ DE PRESSE
Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
Initial proof-of-concept results show crofelemer's efficacy in reducing TPN for intestinal failure patients. Jaguar seeking partnerships for drug development and commercialization -
-
COMMUNIQUÉ DE PRESSE
Cordovacann (CSE: CDVA / OTCQB: LVRLF) Provides Update on Star Buds Cannabis Co. Retail Operations and Exits Oregon and Washington
CordovaCann Corp. reports strong performance of Star Buds Cannabis Co. stores in Canada in 2025, plans to wind down operations in Oregon and Washington -
COMMUNIQUÉ DE PRESSE
Amaze Surpasses 200 Million Storefront Visits, Solidifying Leadership in Rapidly Expanding Creator Economy
Amaze Software, Inc., a leader in creator-powered commerce, surpasses 200 million storefront visits, fuelled by 13 million global creators. Strategic growth reflects creator monetization trends
